1.
The Dysregulation of mir-21 and mir-143 as a clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients with Gastrointestinal Sarcoma. Journal of Pharmaceutical Negative Results. 2022;13(3):20-25. doi:10.47750/pnr.2022.13.03.004